AusCann is a pharmaceutical company focused on the development, production, and distribution of cannabinoid-based medicines within Australia and internationally
AusCann is an Australian-based pharmaceutical company focused on the development, production, and distribution of cannabinoid-based medicines within Australia and internationally.
Our key difference is the commitment to a rigorous pharmaceutical development program, focused on providing reliable, stable and standardised cannabinoid-based pharmaceutical products, whilst generating the clinical evidence to support market access.
We have built a strong team of experts and partners with both local and international connections. Our team has the right expertise across all aspects of the pharmaceutical value chain.
Our immediate focus is on providing healthcare professionals with solutions to optimise treatment outcomes for their patients. To do that, we developed an innovative formulation that is contained in a standardised capsule. AusCann’s capsules are designed to enable accurate dosing.
Revolutionising cannabinoid-based medicines through innovation
To develop a differentiated portfolio of innovative and standardised cannabinoid-based medicines that expands the therapeutic applications of cannabis, offering more patients greater benefit for the treatment of inadequately met medical needs. We will do this by providing healthcare professionals with reliable pharmaceuticals plus the tools to personalise treatment algorithms for their patients in global jurisdictions with relevant regulatory legislation that offer a compelling return on investment.
To act with integrity and the highest standards of ethics when dealing with stakeholders, including employees, suppliers, partners, customers and shareholders
To support healthcare professionals regarding the use of cannabinoid-based pharmaceuticals, through education with informed materials
To trust colleagues, share information and achieve organisational goals by working together as an effective team
To ensure that AusCann’s products are standardised, consistent and reproduceable, based on Good Manufacturing Practice
To develop and manufacture novel cannabinoid-based pharmaceuticals that are formulated to address unmet medical needs for patients
Environmental, social and governance
To minimise our environmental footprint; ensure all products are socially sourced; and maintain exemplary corporate governance practices